Search bioRxiv⌕ Search

Biology subjects

Belhadj, S.

Publications and source records attributed to Belhadj, S..

2 recordsLinked to original sources

Visualizing cell death in live retina: Using calpain activity detection as a biomarker for retinal degeneration

Calpains are a family of calcium-activated proteases involved in numerous disorders. Notably, previous studies have shown that calpain activity was substantially increased in various models for inherited retinal degeneration (RD). In the present study, we tested the capacity of the t-BOC-Leu-Met-CMAC calpain-specific substrate to detect calpain activity in living retina, in organotypic retinal explant cultures derived from wild-type mice, as well as from rd1 and RhoP23H/+ RD-mutant mice. Test conditions were refined until the calpain substrate readily detected large numbers of cells in the photoreceptor layer of RD retina but not in wild-type retina. At the same time, the calpain substrate was not obviously toxic to photoreceptor cells. Comparison of calpain activity with an immunostaining for activated calpain-2 furthermore suggested that individual calpain isoforms may be active in distinct temporal stages of photoreceptor cell death. Notably, calpain-2 activity may be a relatively short-lived event, occurring only towards the end of the cell death process. Finally, our results support the development of calpain activity detection as a novel in vivo biomarker for RD, suitable for combination with non-invasive imaging techniques.

neuroscience↗

Composite solid lipid nanoparticles with hydrogel core for delivering small hydrophilic molecules to the retina: an in vitro study using ARPE-19 and 661W cells

In this study, we developed a novel solid lipid nanoparticle (SLN) formulation for drug delivery of small hydrophilic cargo to the retina. The new formulation, based on a gel core and composite shell, allowed up to two times increase in the encapsulation efficiency. The type of hydrophobic polyester used in the composite shell mixture affects the particle surface charge, colloidal stability, and cell internalization profile. We validated the SLN capability as a drug delivery system by performing encapsulation of a hydrophilic neuroprotective cyclic guanosine monophosphate analogue, previously demonstrated to hold retinoprotective properties, and the best formulation resulted in particles with size of {+/-} 250nm, anionic charge > -20 mV, and an encapsulation efficiency value of {+/-}60%, criteria that are suitable for retinal delivery. In vitro studies using ARPE-19 and 661W retinal cell lines revealed a relatively low SLN toxicity, even when high particle concentration was used. More importantly, SLN could be uptaken by the cells and the release of the hydrophilic cargo in the cytoplasm was visually demonstrated. These findings suggest that the newly developed SLN with a gel core and composite polymer/lipid shell holds all characteristics suitable for drug delivery of small hydrophilic active molecules into retinal cell.

neuroscience↗